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Endocannabinoids, particularly 2-arachidonoyl glycerol (2-AG), impact the directional turning and motility of a developing axon by
activating CB1 cannabinoid receptors (CB1Rs) in its growth cone. Recent findings posit that sn-1-diacylglycerol lipases (DAGL/)
synthesize 2-AG in themotile axon segment of developing pyramidal cells. Coincident axonal targeting of CB1Rs andDAGLs prompts the
hypothesis that autocrine 2-AG signaling facilitates axonal outgrowth. However, DAGLs alone are insufficient to account for the spatial
specificity and dynamics of 2-AG signaling. Therefore, we hypothesized that local 2-AG degradation by monoacylglycerol lipase (MGL)
must play a role. We determined how subcellular recruitment of MGL is temporally and spatially restricted to establish the signaling
competence of 2-AG during axonal growth. MGL is expressed in central and peripheral axons of the fetal nervous system by embryonic
day 12.5. MGL coexists with DAGL and CB1Rs in corticofugal axons of pyramidal cells. Here, MGL and DAGL undergo differential
axonal targeting with MGL being excluded from the motile neurite tip. Thus, spatially confined MGL activity generates a 2-AG-sensing
microdomain and configures 2-AG signaling to promote axonal growth. Once synaptogenesis commences, MGL disperses in stationary
growth cones. The axonal polarity of MGL is maintained by differential proteasomal degradation because inhibiting the ubiquitin
proteasome system also induces axonal MGL redistribution. Because MGL inactivation drives a CB1R-dependent axonal growth re-
sponse, we conclude that 2-AGmay act as a focal protrusive signal for developing neurons andwhose regulatedmetabolism is critical for
attaining correct axonal complexity.
Introduction
Acquisition of a characteristic neuronal cytoarchitecture and
connectivity pattern relies on signaling cassettes whose coordi-
nated expression and temporal interplay drive neuronal identifi-
cation in the developing nervous system (Iba´n˜ez and Ernfors,
2007; Fishell and Hanashima, 2008). Endocannabinoid (eCB) sig-
naling affects neural state change decisions either directly (Berghuis
et al., 2007)orby interactingwithneurotrophin(Maisonetal., 2009)
or cytokine signaling (Zorina et al., 2010). The discovery that neu-
ronal lineage commitment and axonal polarization coincide with
CB1 cannabinoid receptor (CB1R) expression (Coutts et al., 2001;
Begbie et al., 2004; Berghuis et al., 2007; Mulder et al., 2008) and
persist in the presence of a particularly high 2-arachidonoyl glycerol
(2-AG) tone (Berrenderoet al., 1999)prompted theview thatdown-
stream signaling fromCB1Rs diversifies the cellular outcome of eCB
signaling indevelopingneurons (Bromberg et al., 2008). In contrast,
the developmental dynamics of 2-AG signaling entailing coordi-
nated expression of the 2-AG synthesizing and degrading enzymes
sn-1-diacylglycerol lipases / (DAGL/) (Bisogno et al., 2003)
andmonoacylglycerol lipase (MGL) (Dinhet al., 2002), respectively,
remain essentially unexplored. Understanding spatial and temporal
constraints of the metabolic network responsible for regulating
2-AG bioavailability is necessary to appreciate the physiological sig-
nificance of 2-AG in the hierarchy of integrative signaling networks
that determine neuronal identity.
Received April 26, 2010; revised Aug. 6, 2010; accepted Aug. 13, 2010.
This work was supported by the Scottish Universities Life Science Alliance (T.H.), European Molecular Biology
Organization Young Investigator Programme (T.H.), SwedishMedical Research Council (T.H.), Alzheimer’s Research
Trust UK (T.H.), Alzheimer’s Association (K.M., T.H.), European Commission Grant HEALTH-F2-2007-201159 (T.H.),
Grant-in-Aid for Scientific Research fromtheMinistry of Education, Culture, Sports, Science, andTechnologyof Japan
(Y.Y.), Takeda Science Foundation (Y.Y.), the March of Dimes Birth Defects Foundation (Y.M.M.), the Kavli Institute
for Neuroscience at Yale University (Y.M.M.), and National Institutes of Health Grants DA023214 (T.H.), DA11322
(K.M.), and DA21696 (K.M.). We thank C. Ledent and Y. A. Barde for colony founders of CB1R
/ and tau–EGFP
mice, respectively. Y. Zilberter,H.-C. Lu, R. Iyengar, R.A. Ross, andP.Doherty areacknowledged for their constructive
criticism. We thank R. Hessling and J. Lindenau (Carl Zeiss) for expert advice and assistance with quantitative
immunofluorescence analysis.
*E.K. and K.B. contributed equally to this work.
Correspondence should be addressed to Dr. Tibor Harkany, European Neuroscience Institute at Aberdeen, Uni-
versity of Aberdeen, Foresterhill Campus, Ashgrove Road West, Aberdeen AB25 2ZD, United Kingdom. E-mail:
t.harkany@abdn.ac.uk.
DOI:10.1523/JNEUROSCI.2126-10.2010
Copyright © 2010 the authors 0270-6474/10/3013992-16$15.00/0
13992 • The Journal of Neuroscience, October 20, 2010 • 30(42):13992–14007
The process of directional axonal growth relies onmultimodal
communication between individual axons while they navigate
through brain microdomains presenting a spectrum of attractive
and repulsive guidance cues (Xiang et al., 2002). eCB signaling is
a novel mechanism positioned to facilitate corticofugal axon
(CFA) development (Watson et al., 2008) because axonal target-
ing of DAGL/ can generate cell-autonomous 2-AG microgra-
dients engaging CB1Rs in motile growth cones (Bisogno et al.,
2003). Alternatively, 2-AG released from corticofugal axons can
act as a paracrine guidance signal and limit premature dispersion
of axon collaterals by establishing permissive pathfinding corri-
dors (Mulder et al., 2008). Accordingly, impaired CB1R function
during growth cone navigation presents an aberrant axon fascic-
ulation and postsynaptic target selection phenotype (Berghuis et
al., 2007; Watson et al., 2008). However, the above model is in-
complete because it neither identifies an axonal domain whose
cytoskeletal dynamics are particularly sensitive to eCBs nor ex-
plains how eCB actions are restricted to the distal motile axon
segment to drive its unidirectional extension. Therefore, an ade-
quate mechanistic concept must imply focal 2-AG-degrading ac-
tivity, likely produced by MGL, known to degrade 85–90% of
2-AG in adult brain homogenates (Blankman et al., 2007), to
restrict 2-AG signaling to the navigating growth cone and away
from the consolidating neurite shaft.
Here, we explored the developmental dynamics of MGL ex-
pression and its spatial relationship with CB1R and DAGL/
during forebrain development. We identify a metabolic regula-
tory network allowing both autocrine and paracrine 2-AG signal-
ing to operate in developing brain with CB1R being dispensable
to regulate the expression and correct axonal targeting of both
MGL and DAGL. We directly implicate 2-AG signaling in axon
development by demonstrating that site-directed MGL inactiva-
tion triggers a CB1R-dependent axonal growth response.
Materials andMethods
Animals and tissue preparation. Mouse embryos (n  6 per time point,
n 2 pregnancies per analysis) were obtained from time-mated C57BL/
6/N, GAD67–green fluorescent protein-positive (GFP) (neo)
(Tamamaki et al., 2003), tau–enhanced GFP (EGFP) (Tucker et al.,
2001), orCB1R
/ and correspondingCD1wild-typemice (Ledent et al.,
1999) at embryonic day 12.5 (E12.5) to E18.5.Whole brainswere immer-
sion fixed in 4% paraformaldehyde in Na-phosphate buffer (0.1 M, pH
7.4) overnight. Tissue samples were cryoprotected in 30% sucrose in
physiological saline for at least 48 h before cryostat sectioning (16 m
thickness) and thawmounting on SuperFrost glass slides. Experiments
conformed to the 86/609/EEC directive and were approved by the Home
Office of the United Kingdom.
Histochemical expression profiling and quantitative microscopy. Basic
concepts of forebrain development are discussed in the supplemental
information (available at www.jneurosci.org as supplemental mate-
rial). Serial sections were processed according to published protocols
(Berghuis et al., 2007) with select combinations of primary antibodies
(supplemental Table 1A,A1, available at www.jneurosci.org as supple-
mental material). Hoechst 35,528 (Sigma), a nuclear dye, has been ap-
plied to reveal tissue architecture. Antibodies raised against CB1R, its
C-terminal interacting protein 1a isoform (CRIP1a), DAGL, andMGL
(Twitchell et al., 1997; Yoshida et al., 2006; Uchigashima et al., 2007;
Straiker et al., 2009) were independently validated by at least two of the
following methods: (1) preadsorption of primary antibodies with their
corresponding fusion protein (5 g/ml) in vitro and/or in vivo, (2) colo-
calization with hemagglutinin-tagged target protein heterologously ex-
pressed in human embryonic kidneyHEK293 cells, (3) lack of staining in
corresponding null mice (data not shown for DAGL or MGL), or (4)
identical staining patterns by multiple antibodies recognizing distinct
epitopes within a target protein (supplemental Figs. 1–3, available at
www.jneurosci.org as supplemental material).
Sections were inspected, and images were acquired on a 710LSM con-
focal laser-scanning microscope (Carl Zeiss) equipped to separate emis-
sion signals through spectral detection and unmixing. Emission spectra
for each dye was limited as follows: Hoechst (420–485 nm), carbocya-
nine 2 (Cy2) (505–530 nm), Cy3 (560–610 nm), andCy5 (640–720 nm).
Image surveys were generated using the tile scan function with optical
zoom ranging from 0.6 to 1.5 at 10 primary magnification (objec-
tive, EC Plan-Neofluar 10/0.30). Images were processed using the
ZEN2009 software (Carl Zeiss). Multipanel figures were assembled in
CorelDraw X3 (Corel Corp.).
Colocalization was defined as immunosignals being present without
physical signal separation in 1.0 m optical slices at 40 (Plan-
Neofluar 40/1.30) or 63 (Plan-Apochromat 63/1.40) primarymag-
nification (Mulder et al., 2009). The colocalization utility of theZEN2009
software package was used to determine (1) the relative area occupancy
for each fluorochrome, defined as the density of fluorescence pixels nor-
malized to a 1 m2 surface area, (2) the colocalization coefficient of
CB1R versus MGL immunoreactivities in the cortical plate or thalamus,
expressed as the relative number of colocalizing pixels in one channel
compared with the total number of pixels above threshold in another
channel, and (3) Pearson’s correlation coefficient defining the intensity
distribution within colocalizing regions (ranging from1 to1, with 0
indicating no correlation).
Preembedding electron microscopy. E13–E13.5 mouse embryos were
decapitated, and brains were immersion fixed overnight (Morozov et al.,
2009). Preembedding immunoperoxidase labeling to localize CB1Rs in
coronal vibratome sections (100 m) was performed with specimens
subsequently osmificated and contrasted (Morozov et al., 2009).
In utero electroporation. At E11.5, in utero electroporation was per-
formed as described previously (Torii et al., 2009) by injecting a DNA
solution containing a pCAGGS–EGFP plasmid at a concentration of 0.5
mg/ml using a pulled glass capillary. Electroporation was performed us-
ing a BTXECM830 square wave electroporator with five electric pulses at
25 V for 50 ms each with 950 ms intervals (Morozov et al., 2009). Dams
were decapitated after 3–6 d, and embryos were removed and inspected
for EGFP fluorescence (Stemi SV11 Apo; Carl Zeiss). EGFP-expressing
brains were immersion fixed and sectioned, and CB1Rs were localized as
above.
Neuronal cultures, immunocytochemistry, and morphometry. Embry-
onic cortices and hippocampiwere dissected at E14.5 or E16.5. Cells were
dissociated by trypsin (0.1%) and plated on coverslips coated with poly-
D-lysine (PDL) (Sigma). Cultured neurons (30–50,000 cells per well in
24-well plates) were maintained for 2 or 4 d in vitro (DIV) as described
previously (Mulder et al., 2008). Lactacystin (20 M; Tocris Bioscience),
an irreversible inhibitor of the 20S proteasome, the DAGL inhibitors
tetrahydrolipstatin (THL) (1M; Sigma) andO-3841 (1M) (Bisogno et
al., 2006), the MGL inhibitors JZL184 (100 nM; Cayman Chemical)
(Long et al., 2009) and URB 602 (5 M; Cayman Chemical) (King et al.,
2007), and the neutral CB1R antagonist O-2050 (200 nM; Tocris Bio-
science) were added to modulate axonal MGL distribution and growth
rates as well as to induce growth cone collapse. Immunocytochemistry
was performed with select combinations of primary antibodies (supple-
mental Table 1, available atwww.jneurosci.org as supplementalmaterial)
(Berghuis et al., 2007). TheDotti stagingmethodwas used to define axon
development (Dotti et al., 1988). Images of cortical neurons and their
axons were captured by means of laser-scanning microscopy (model
710LSM; Carl Zeiss). Neurite length and the surface area of individual
growth cones were determined at the time points indicated (see Fig. 9) by
analyzing calibrated images in the LSM5 image browser softwaremodule
(version 3.2.0.115; Carl Zeiss).
PCR. E16.5 embryonic brains (n  4) were microdissected on ice to
isolate cortical and thalamic regions and snap frozen in liquid N2 until
processing. Primary cultures from cortex and thalamus were established
at E16.5 andmaintained for 4 DIV at a density of 1 106 cells per well in
PDL-coated six-well plates (n 2 per region). RNA was extracted using
the RNeasymini kit (Qiagen) with aDNase I step performed to eliminate
traces of genomic DNA (supplemental Fig. 4A1,A2, available at www.
jneurosci.org as supplemental material) and reverse transcribed using a
high-capacity cDNA reverse transcription kit (Applied Biosystems).
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Quantitative PCRs were performed after an initial 10 min 95°C denatur-
ation followed by 40 cycles of 95°C for 15 s denaturation, annealing and
extension at calculated temperatures (60 s), and a dissociation stage
(from 60 to 95°C with 0.5°C steps for 10 s each) (MyiQ; Bio-Rad), with
primer pairs amplifying short fragments for each gene (supplemental Fig.
4B, available at www.jneurosci.org as supplemental material). Samples
without template or reverse transcriptase served as negative control. Ex-
pression levels were obtained by subtracting the value for each sample in
the absence of reverse transcriptase from the corresponding value in the
presence of reverse transcriptase and then normalizing to the housekeep-
ing gene encoding glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) obtained for every sample in parallel assays (Berghuis et al.,
2005).
Western blotting. Tissue samples were lysed in modified radioimmu-
noprecipitation assay buffer containing 1 mM NaF, 1 mM Na3VO4, 0.1%
N-octyl--D-glucopyranoside, and a mixture of protease inhibitors
(Roche), denatured in 5 Laemmli’s buffer, and analyzed by SDS-PAGE
(30 g of protein per sample) (Berghuis et al., 2005). Membranes were
blocked in Odyssey blocking buffer (LiCor Biosciences) for 1 h and ex-
posed to primary antibodies (supplemental Table 1, available at www.
jneurosci.org as supplemental material) overnight at 4°C. -III-Tubulin
(1:2000; Promega) or-actin (1:10,000; Promega) served as loading con-
trol. Appropriate combinations of IRDye800 and IRDye680 antibodies
(fromgoat or rabbit hosts; 1:10,000, 2 h; LiCor Biosciences)were used for
signal detection on a LiCor Odyssey IR imager. Integrated optical densi-
ties were determined using NIH ImageJ 1.32j. Experiments were per-
formed in triplicate.
Liquid chromatography tandem mass spectrometry. 2-AG concentra-
tions were determined using a solid-phase extraction liquid chromatog-
raphy tandemmass spectrometry (LC-MS/MS)method (Giuffrida et al.,
2000). Tissues from n  4–8 embryos per developmental stage were
homogenized in ice-cold acetonitrile containing [ 2H4]anandamide
(AEA) at 6 pmol as the internal standard, made up to 70% water and
centrifuged at 13,000 rpm for 5 min. The supernatant was applied to
Strata-X polymeric reversed-phase cartridges (Phenomenex), methanol-
eluted analytes were dried under N2, and the residue was resuspended in
mobile phase. A Surveyor LC system coupled to a TSQ Quantum mass
spectrometer (Fisher Thermo Scientific) was used for analysis. The ana-
lytes were eluted from an ACE 5 C8 column (150 2.1 mm; Hichrom
Ltd.) under isocratic conditions with a mobile phase consisting of 15%
water, 85%methanol, and 0.5% formic acid at a flow rate of 200 l/min
at 30°C. MS analysis was performed using electrospray ionization in
positive ion mode. Quantification was undertaken using single-reaction
monitoring of the parent ion–product ion transitions for 2-AG and
[2H4]AEA of mass-to-charge ratio (m/z) ofm/z 379 tom/z 287 andm/z
352.2 tom/z 66.2, respectively. Two peaks were present in the chromato-
gram for 2-AG because a 1(3)-isomer exists in equilibrium with 2-AG.
The areas of both peaks were combined to calculate [2-AG] by weighted
linear regression analysis against suitable calibration standards using
Xcalibur 2.0.6 software (Fisher Thermo Scientific). Results were ex-
pressed as nanomoles per gram of tissue.
Statistics. A p value of 0.05 was considered statistically significant
(Student’s t test) (SPSS version 16.0). Data were expressed as means 
SEM. Fluorescence intensity distributions in individual axons were
calculated by NIH ImageJ 1.32j and plotted in GraFit 5.0 (Erithacus
Software).
Results
Developmental dynamics of MGL expression
CB1R and DAGL expression and function are tightly regulated to
modulate neuronal polarization and axonal growth in the devel-
oping nervous system (Bisogno et al., 2003; Leterrier et al., 2006;
Berghuis et al., 2007; Vitalis et al., 2008; Maison et al., 2009;
Walker et al., 2010). Both pyramidal cells and interneurons rely
on CB1Rs to transduce eCB signals (Berghuis et al., 2007; Mulder
et al., 2008). DAGL expression and cell-autonomous activity are
retained only by pyramidal cells, whereas GABAergic interneu-
rons depend on extracellular 2-AG cues (Walker et al., 2010). In
contrast, the spatiotemporal dynamics of MGL expression and
function in the developing nervous system remain unknown.
We generated polyclonal antibodies raised against distinct
MGL epitopes (supplemental Table 1, supplemental Fig. 3, avail-
able at www.jneurosci.org as supplemental material) to deter-
mine the distribution pattern of MGL in the developing nervous
system of the mouse. We find MGL progenitors residing in the
ventricular (VZ) and subventricular (SVZ) zones of the telence-
phalic vesicles at E12.5 (Fig. 1A–A2). MGL
 pioneer axons are
committed to the olfactory nerve (Fig. 1A1) and thalamic projec-
tions (Fig. 1A2) at this developmental stage. However, GFP

GABAergic neurons migrating toward the cerebral cortex lack
appreciable MGL expression (Fig. 1A1,A2).
We used homozygous tau–EGFP mice to resolve the subcel-
lular distribution of MGL in the developing mouse brain (Fig.
1B,B1) as well as peripheral ganglia and nerves at E14.5. tau–
EGFP mice were constructed by placing EGFP cDNA in-frame
with the endogenous initiation codon of the tau gene such that a
fusion protein is produced comprising the first 31 aa of tau fol-
lowed by EGFP (Tucker et al., 2001). The chimeric protein is
particularly advantageous in a developmental context because
EGFP replaces the C-terminal microtubule-binding domains of
tau, resulting in an entirely cytoplasmic EGFP signal in projection
neurons, such as Brn-1 cortical pyramidal cells (Fig. 1D3)
(Sugitani et al., 2002) but not in GABA interneurons (data not
shown).
Peripheral ganglia, including trigeminal (Fig. 1C) and dorsal
root ganglia (data not shown), harbored many MGL neurons.
Consequently, MGL axons concentrated in facial and mandib-
ular trunks of the trigeminal nerve, including those innervating
the whiskers, the spinal trigeminal tract (Fig. 1C1,C2), and the
stalk of the optic nerve (Fig. 1C1). MGL
 central structures in-
clude the parabrachial/microcellular tegmental nucleus and the
colliculi superior and inferior (Fig. 1C1,C3). In the forebrain, the
olfactory nerve, VZ/SVZ progenitors, postmitotic cortical neu-
rons, and axons coursing along the palliosubpallial boundary,
presumed thalamocortical axons (TCAs), were MGL (Fig.
1C,C1). By analyzing coronal sections of the fetalmouse brain, we
confirmed that both optic nerves and TCAs traversing the infe-
rior thalamic radiation (Fig. 1D,D1) are MGL
. MGL TCAs
advance in the subplate as far as the medial pallial fold (Fig. 1D2)
and coexist with radially migrating MGL postmitotic neurons
exiting the SVZ (but not RC2 radial glia) and MGL-negative
(MGL)/GFP GABA cells migrating tangentially in the mar-
ginal zone of this cortical domain. In the lateroventral isocortex,
MGL ascending TCAs appear intermingled with radially mi-
grating Brn-1/MGL cortical pyramidal cells and can target
these cells once they reached the cortical plate (Fig. 1D4).
Most long-range forebrain tracts (Fig. 1E), including the pe-
ripheral (Fig. 1E1) and central segments (Fig. 1E2) of the optic
nerve, lateral olfactory tract, fimbria hippocampi, and TCAs, re-
cruit MGL axons by E16.5, which we recognize as the develop-
mental stage after which axonal MGL targeting terminates. After
this time,MGL is restricted to the perisomatic segment and prox-
imal dendrites both in the late-gestational brain (Fig. 1F) and at
birth (data not shown). We find that restricted MGL expression
inversely correlates with cortical and hippocampal 2-AG concen-
trations (Fig. 1G): 10.2 1.1 (E14.5), 13.9 3.2 (E16.5), 13.21
1.8 (E18.5) ng/mg tissue versus 21.2  4.2 postnatal day 0 (P0),
35.78 7.8 (P1; p 0.05 vs all fetal groups examined), 44.4 9.8
ng/mg tissue (P2; p 0.05 vs all fetal groups examined). Collec-
tively, our data suggest that MGL plays an essential role in deter-
mining 2-AG availability in the developing nervous system.
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Figure1. MGL localization in thedevelopingnervous system.A–A2,MGL
olfactory (A1, arrows) and thalamic axons (A2, arrows), ventricular zoneprogenitors (openarrowheads), andprecursor
cells populating the striatal differentiation zone (sdz) are present by E12.5. B, B1, Semiquantitative assessment of MGL distribution in postmitotic neurons of cerebral subfields. Incrementing
horizontal linewidth correlateswith increasing signal intensity. C–C3, Sagittal section across the brain and upper body segment of a homozygous tau–EGFP
 embryo (Figure legend continues.)
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Regional differences in 2-AG synthesis and degradation in the
corticothalamic axis
Previous studies support the notion that CB1Rs are primarily
expressed in the developing neocortex (Berghuis et al., 2007;
Vitalis et al., 2008;Morozov et al., 2009). Our present histochem-
ical findings, however, place the primary site ofMGL synthesis in
the developing thalamus. We performed quantitative real-time
PCR (qPCR) analysis to support spatial differences in 2-AG syn-
thesis and degradation. In embryonic cortices and thalami iso-
lated at E16.5 (n  4), we have found that MGL mRNA levels
(1.17  0.07; unscaled normalized values throughout) signifi-
cantly exceed those found in the cerebral cortex (0.85  0.04)
when normalized to GAPDH ( p  0.009) (Fig. 2A). Similarly,
DAGL mRNA expression was also significantly higher in the
thalamus (1.09 0.03) than in the cerebral cortex (0.81 0.05;
p  0.003) (Fig. 2B). Conspicuously, DAGL coexists with
DAGL at E16.5 (Fig. 2C) and exhibits similar regional variations
(0.95 0.02 for thalamus vs 0.055 0.03 for cortex; p 0.001).
In contrast, CB1R mRNA levels in the cerebral cortex exceed
those in thalamus (0.88  0.06 for thalamus vs 1.08  0.05 for
cortex; p 0.035) (Fig. 2D).
Next, we have performed qPCR analysis of primary cortical
and thalamic neurons isolated at E16.5 andmaintained for 4 DIV
to validate subsequent cell biology studies (see Figs. 5–9) in cor-
tical neurons endogenously expressingMGL, CB1R, and DAGLs.
We show that both neuron populations maintain their cellular
specificities of expressing molecular components of the 2-AG
signaling cassette (n  2) (Fig. 2A–D) compared with data
obtained in vivo (Fig. 2A–D).
To further dissect whether expression ofmetabolic and recep-
tor components of the 2-AG signaling system at the protein level
is temporally coordinated, we analyzed pallial/cortical tissues
(Fig. 2E–E3) and subpallial/striatal specimens (supplemental Fig.
5, available at www.jneurosci.org as supplemental material) by
Western blotting. We demonstrate that the 33 kDa isoform of
MGL is selectively expressed in embryonic brain tissue (Fig. 2E).
Comparative analysis of this isoform from E14.5 to P1 supports
4
(Figure legend continued.) photographed at E14.5 reveals MGL axons in the trigeminal
ganglion (5Gn), submandibular trigeminal nerves (5man), and spinal trigeminal tract (sp5; C2),
optic stalk (os), parabrachial/microcellular tegmental nuclei (PB/MiTg;C3), and thalamocortical
(arrowheads) and olfactory tracts (1n). Open arrowheads indicate MGL subventricular zone
progenitors. D–D4, MGL
 TCAs course in the inferior thalamic radiation (D1) before invading
the cortical subplate (D2, arrows). D1, MGL
 axons at the anterodorsal thalamic boundary are
intermingled with GABAergic neurons. D2, Radially migrating cortical neurons, presumed py-
ramidal cells, also express MGL. Note that GFP GABAergic interneurons are MGL at this
developmental stage.D3, Brn-1
/tau–EGFP pyramidal cells (arrowheads)migrate through
the MGL subplate to reach their final positions. D4, MGL
 puncta are in close apposition to
tau–EGFP cortical neurons (arrowheads). E–E2, MGL
 axons populate the cortical IZ, hip-
pocampal fimbria (f), lateral olfactory tract (lot), and optic nerves (och) by E16.5. Note that the
striatal neuroepithelium (ne) lacks appreciable MGL expression. F, F1, By E18.5, MGL becomes
restricted to neuronal perikarya and disappears from long-range axons. G, Increased [2-AG]
coincides with MGL redistribution by birth. *p 0.05 versus E14.5–E18.5 (Student’s t test).
Open rectangles denote the location of insets. Abbreviations used in all figures are listed in the
supplemental information (available at www.jneurosci.org as supplemental material). Scale
bars: A, A2, C–C2, D, E, F, 100m; A1, D1–D3, 25m; D4, E1, E2, F1, 10m.
Figure 2. Foci of MGL expression and the developmental dynamics of 2-AG signaling. A–D, Comparative analysis of the expression levels of 2-AG metabolic enzymes and CB1Rs in fetal mouse
brain at E16.5. Data were normalized to GAPDH, a housekeeping gene. *p 0.05, **p 0.01, cortex versus thalamus. A–D, Cortical and thalamic neurons maintain region-specific differences
in their expression of MGL, CB1R, and DAGL/ after 4 DIV (n.f.e., normalized fold expression). E, The 33 kDa isoform of MGL predominates in fetal brain. E1, Western blot analysis of metabolic
components of 2-AG signaling networks during successive stages of corticogenesis.-III-Tubulin served as protein loading control. Discordant CB1R and CRIP1a expression patterns suggest a lack
of interactionor temporally restrictedCRIP1a recruitment to CB1Rs.E2,E3, Quantitative analysis of fetal DAGL,MGL, andCB1R, CRIP1aprotein levels. Datapoints representmeanSEM; integrated
optical density values from n 3 independent experiments. Neonatal cortices were used to normalize expression levels (*p 0.05, **p 0.01, Student’s t test).
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our histochemical findings by revealing transiently decreased
MGL protein levels at approximately E.18.5 [E18.5, 0.49  0.11
vs P1 (cortex), 1.0 0.00 (normalized); p 0.010] (Fig. 2E1,E2)
(supplemental Fig. 5A1,A2). In contrast, DAGL expression
peaks at E14.5/E16.5 with a dramatic decrease in DAGL protein
concentrations in neonates [E14.5, 14.41  6.21 vs P1 (hip-
pocampus), 0.96  0.34 (values were normalized to P1 cortical
levels); p 0.044] (Fig. 2E1,E2) (supplemental Fig. 5A1,A2, avail-
able at www.jneurosci.org as supplemental material). CB1R pro-
tein levels are essentially unchanged throughout forebrain
development (Fig. 2E1,E3) (supplemental Fig. 5A1,A3, available at
www.jneurosci.org as supplemental material).
CRIP1a can interact with the distal C terminus of CB1R
(Niehaus et al., 2007) and may attenuate CB1R-mediated inhibi-
tion of voltage-gated Ca2 channels. However, the developmen-
tal expression profile of CRIP1a in relation to CB1Rs is unknown.
We show that CRIP1a protein levels (supplemental Fig. 1, avail-
able at www.jneurosci.org as supplemental material) are dynam-
ically regulated in the developing nervous system with a
progressive increase in cortical [E14.5, 0.57  0.27 vs P1 (hip-
pocampus), 1.24 0.28 (normalized to CRIP1a levels in P1 cor-
tex); p  0.005] (Fig. 2E1,E3) and subpallial CRIP1a
concentrations by birth [E14.5, 0.44  0.07 vs P1, 1.0  0.00
(normalized); p 0.040] (supplemental Fig. 5A1,A3, available at
www.jneurosci.org as supplemental material). Overall, these ex-
periments indicate that 2-AGmetabolic enzymes andCB1R levels
are controlled at both the mRNA and protein levels in vivo.
CB1Rs in growth cones of cortical pyramidal neurons
CB1Rs have hitherto been demonstrated to accumulate in growth
cones ofGABAergic interneurons (Berghuis et al., 2007) aswell as
in the shaft of CFAs emanating from pyramidal cells (Berghuis et
al., 2007; Vitalis et al., 2008). However, the presence of CB1Rs in
motile growth cones of cortical pyramidal cells is ambiguous.We
studied CB1R distribution at the ultrastructural level by corre-
lated light and electron microscopy. We find that CB1R
 axons
are emitted earlier than thought previously (E13) (Fig. 3A).
CB1Rs are distributed along the shafts and growth cones of CFAs
that depart the cortical intermediate zone (IZ) and transit the
internal capsule (Fig. 3A,A1). CB1R
 axons navigate in the neu-
ropil of the internal capsule separately from each other (Fig. 3A1).
CB1Rs are transported in small vesicles along the axon (Fig. 3B)
and concentrate in motile filopodia that protrude at random
from individual growth cones (Fig. 3C,C1). Pathfinding decisions
by CB1R
 growth cones do not rely on the alignment of CB1R

axons with each other as we detected using electron microscopy
with three-dimensional reconstruction (Fig. 3A2,C,C1). Thus,
CB1R expression during CFA tract formation is poised to allow
eCBs to influence both the elongation and growth cone steering
decisions of excitatory cortical efferents.
Our present and previous (Berghuis et al., 2007; Mulder et al.,
2008) findings suggest that CB1Rs are selectively expressed by
cortical neurons, including pyramidal cells, and can affect the
elongation and guidance of CFAs. We tested this notion by elec-
troporating cortical pyramidal cells and thalamic projection neu-
rons with an EGFP vector in utero. Our data demonstrate that
CB1Rs are present in CFAs coursing deep in the IZ (Fig. 3D1–d3)
but absent from superficial TCAs (Fig. 3E1–e3). By using high-
resolution laser-scanning microscopy, we clearly show colocal-
ization of pyramidal cell-derived EGFP and CB1R signals (Fig.
3d1–d3) while revealing a mutually exclusive distribution pat-
tern of CB1Rs and EGFP expressed by thalamic neurons (Fig.
3e1–e3). Overall, our results define the axonal specificity of
CB1Rs during corticogenesis.
MGL and CB1Rs are coexpressed in corticofugal but not
thalamocortical axons
The presence of MGL mRNA in the cerebral cortex suggests that
MGL expression persists in developing cortical neurons. We ex-
amined MGL expression by cortical pyramidal cells by analyzing
whether MGL colocalizes with CB1Rs (Fig. 4A) that we have
characterized as a specific pallial marker (Fig. 3D3). High-
resolution microscopy revealed that pyramidal cells populating
the cortical plate at E16.5 harbor both MGL and CB1R immuno-
reactivities (Fig. 4A1). Accordingly, MGL
/CB1R
 axons popu-
lated the IZ of the cerebral cortex (Fig. 4A2). We observed that
MGL axons aremore numerous in the IZ than those containing
CB1Rs [area occupancy (percentage of region of interest), 31.7
3.0% (CB1R
) vs 68.4 3.0% (MGL)] (Fig. 4C), with 6.7
1.3% of MGL axons also containing CB1Rs. Conversely,
13.1  2.0% of CB1R
 axonal profiles harbored MGL immu-
noreactivity (Fig. 4C1).
In the thalamus, however, MGL axonal profiles were far
more frequently encountered than CB1R
 profiles [area occu-
pancy (percentage of region of interest), 94.7 2.0% (MGL) vs
5.3  2.0% (CB1R
)] (Fig. 4B–B1	,C). Only 1.0  0.1% of
MGL axons contained CB1Rs, whereas 17.9  4.8% of CB1R-
containing axonal profiles were dual labeled (Fig. 4C1). The Pear-
son’s correlation coefficient of dual-labeled structures did not
differ from R  0, suggesting a lack of a direct relationship (co-
regulation) of CB1R andMGL levels in individual axonal profiles
(Fig. 4C2).
We found that MGL and CB1R
 axons are spatially segre-
gated in the fimbria hippocampi (Fig. 4D). In fact, the fimbria
can be subdivided into ventrolateral/CB1R
, median/mixed, and
dorsomedial/MGL domains in coronal sections (Fig. 4D1–D3).
We have confirmed this notion by quantitative morphometry
showing inverse MGL/CB1R colocalization probabilities in these
domains (Fig. 4D4). Together, these findings suggest that CB1Rs
can coexist with MGL in CFAs. In contrast, the overwhelming
majority of TCAs only contain MGL (Fig. 4E). Therefore, we
suggest that TCAs can function as 2-AG-inactivating barriers to
shape forward-facing 2-AG gradients, to minimize 2-AG “spill-
over” and to promote CFA pathfinding.
CB1Rs are indispensable for axon fasciculation but
dispensable for DAGL orMGL expression and axonal
targeting
The physiological outcome of eCB signaling is determined hier-
archically byCB1Rs being available at the cell surface (Hsieh et al.,
1999), their differential recruitment of signal transduction path-
ways (Derkinderen et al., 2003), as well as the momentary meta-
bolic balance between 2-AG synthesis (DAGL) and degrading
(MGL) activities. Our present and previous data (Mulder et al.,
2008) together establish that MGL is coexpressed and cotargeted
with CB1Rs and DAGLs in CFAs at midgestation. The coincident
presence of enzymatic and receptor components of 2-AG signal-
ing in CFAs allows us to address whether DAGL and MGL
expression and axonal targeting in fasciculating CFAs are linked
to CB1Rs. We tested this possibility in E16.5 CB1R
/ mice that
exhibit enlarged CFA fascicles relative to their age-matched wild-
type littermates (Mulder et al., 2008). We validated that CB1R
activity in CFAs is indispensable for appropriately timed axonal
elongation and fasciculation to occur as enlarged CFA fascicles
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can be seen in CB1R
/mice when local-
izing both DAGL and MGL (Fig. 5).
Next, we have explored whether the
CB1R itself and/or the redundancy of
signaling-competent 2-AG in the absence
of its cognate receptor can affect DAGL
or MGL expression and CFA targeting.
Neither DAGL (Fig. 5B–B1) nor MGL
(Fig. 5C–C1) expression in cortical terri-
tories is dependent on CB1Rs. In fact, the
bundledCFAphenotype inCB1R
/mice
amplifies the presence of both enzymes
otherwise sparsely distributed in axons
with parallel trajectories in wild-type
cortices (Fig. 5B1,C1). Although we
cannot exclude subtle alterations to the
temporal control of DAGL and/or MGL
expression or degradation in the ab-
sence of CB1Rs, our findings suggest
that CB1R does not exert significant up-
stream control of DAGL and MGL ex-
pression at midgestation.
Mutually exclusive subcellular
distribution of DAGL and
MGL in developing axons
Any guidance cue or elongation factor
requires a discrete subcellular niche,
particularly the growth cone, in which
temporally and spatially restricted ligand–
receptor interactions can occur and trans-
late into a growth response. eCB signaling
has unique properties because this ligand
family is lipophilic and can diffuse in bio-
logical membranes over significant dis-
tances (Chevaleyre et al., 2006) and exert
their action, at least in part, through cell-
autonomous mechanisms (Mulder et al.,
2008). We hypothesized therefore that
2-AG synthesis by DAGL/DAGL
(Mulder et al., 2008) must exceed MGL-
dependent 2-AG degradation in axonal
growth cones to generate 2-AG-rich
hotspots for directional axonal growth.
Individual axons developing in vitro
provide a suitable model to assess this
hypothesis by allowing precise, corre-
lated localization of DAGLs andMGL as
they elongate. Maturation of cortical
neurons is not only characterized by the
spatial expansion of their axons but also
by the appearance of varicose structures
(Dotti et al., 1988), with each varicosity
recognized as a functionally active sig-
naling entity.
In cortical cultures with elaborate yet
immature axonal meshworks (4 DIV), DAGL andMGL coexist
in presynaptic varicosities (Fig. 6A,A1). However, DAGL is
reduced in presynapse-like varicosities (Fig. 6B) once synapto-
genesis concludes (Mulder et al., 2008). In contrast, MGL retains
its presynaptic localization both within fasciculating axons (Fig.
6C) and VAMP2 (synaptobrevin 2) presynapses, whether
autaptic or heterotaptic (Fig. 6D,D1), thus recapitulating the
distribution of MGL in adult brain (Dinh et al., 2002; Gulyas
et al., 2004).
Subcellular analysis revealed that MGL accumulates in tubu-
lin consolidating axon shaftswith its levels tailing off toward the
actin-rich motile axon tip leaving a “barrier region” of 9–12 m
with low MGL levels (termed “MGL delay” throughout) (Fig.
6E–E3). To gain insights into the temporal dynamics of axonal
Figure 3. CB1Rs in corticofugal afferents. A, CB1R
 CFAs with their growth cones (A1, arrowheads) transiting into the internal
capsule by E13.5. Note that all axons grow in the same direction when departing the neocortex (left to right with neocortex being
on the left; A1). A1 is a photomontage of light micrographs merged from different focal planes. Arrowheads A1 and A2 indicate
growth cones thatwere analyzed using electronmicroscopy and subsequent three-dimensional reconstruction.A2, Ultrastructural
analysis of serial sections from a growth cone of a CB1R
 corticofugal axon (identified as 1 in A1) reveals anti-CB1R immunoper-
oxidase reaction end product in thick profiles and filopodial tips (double arrow). B, In the neocortical intermediate zone, the axon
shaft (cross-section profile is encircled with red dotted line) contains numerous CB1Rs (visualized as silver-amplified immunogold
particles; arrows) in small transport vesicles (highlighted semitransparent green) and on the plasmalemmal surface (open arrow-
heads). C, C1, Three-dimensional reconstruction of a growth cone reciprocally rotated
120°. Open arrows point to the truncated
axon shaft. Note the numerous thin filopodia (double arrows) protruding in random directions. D1–E3, Axons of EGFP-expressing
cortical (D1) but not thalamic neurons (E1) are CB1R
 at E16.5. In E1–E3, arrow identifies EGFP
 thalamocortical afferents
residing in a spatially segregated CB1R
 fascicle in the subplate. CFA labeling denotes the location of corticofugal axons in d1–d3
and e1–e3. Filled (d1–d3) but not open (e1–e3) arrowheads identify individual EGFP
/CB1R
 axons of electroporated (EP)
neurons. Scale bars: D3, E3, 500m; A, d3, e3, 100m; A, 10m; d3, e3, 3m; A1, B, 1m; A2, C, C1, 0.5m.
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MGL accumulation, we have compared the distribution of MGL
at successive stages of axon development (Dotti et al., 1988).
MGL is preferentially targeted to the quiescent axon once neuro-
nal polarization occurs (Fig. 6E). Elongating axons retain MGL
in their stable proximal segments (Fig. 6E1) with a surprisingly
steep decrement of MGL toward their actin distal tip (Fig.
6E1,E1). Compartmentalized MGL distribution is a fundamen-
tal hallmark of axon development and is independent of themor-
phology—whether bundled, spread, or looped (Morii et al.,
2006)—of coexisting growth cones (Fig. 6E2–E3). Notably, sub-
cellular DAGL andMGL localization is significantly different in
motile growth cones with DAGL but not MGL being present
(Fig. 6F,G). In conclusion, DAGL and MGL exhibit mutually
exclusive distribution in motile neurites, in which the exclusion
of MGL from the growth cone defines a subcellular niche for
protrusive 2-AG signaling.
Proteasomal degradation is a candidate mechanism to
excludeMGL from growth cones
The ubiquitin proteasome system (UPS) has been implicated in
defining dynamic structural rearrangements during axonal
growth (Haas and Broadie, 2008). Preferential UPS-mediated
degradation of cytoskeletal and signalosome complexes under-
scores the continuous structural reorganization within the
growth cone during its steering decisions (Campbell and Holt,
2001). The restricted localization of MGL to the immobile axon
shaft led us to hypothesize that MGL degradation in the motile
neurite tip could maintain the sensitivity of the growth cone to
2-AG. Bioinformatic tools (http://elm.eu.org) predict a destruc-
tion box motif (D-box) in MGL, suggesting that MGL could be
degraded by the 20S proteasome within the motile axon ending.
We have experimentally tested whether compartmentalized pro-
teasomal degradation contributes to the axonal gradient of MGL
Figure 4. Differential colocalization of CB1Rs andMGL in the cerebral cortex and thalamus. A, Both MGL and CB1Rs are present in long-range forebrain axons. A1, Neocortical pyramidal cells are
immunopositive for both MGL and CB1Rs. A2, In the intermediate zone, a subset of axonal profiles are dual labeled for MGL and CB1R. B–B1, MGL
 axons were found abundant, whereas CB1R

axonal profileswere infrequently encountered in thalamic territories. C, Relative area coverage ofMGL and CB1R
 axons in the cerebral cortex and dorsal thalamus. C1, Colocalization coefficients
for MGL and CB1R immunoreactivities reveal area-specific differences in their probability of colocalization. C2, Pearson’s correlation coefficient of MGL/CB1R approximates 0 in both brain regions
studied. D, The fimbria hippocampi comprises histochemical domains with distinct densities of MGL and CB1R
 axons. D1–D3, MGL concentrates in the dorsomedial fimbria, whereas CB1R

axonal profiles predominate in its ventrolateral extension.D4, Colocalization coefficients forMGL
 and CB1R
 axons in fimbrial subterritories. *p 0.05, **p 0.01 (Student’s t test). E,Working
model of eCB-mediated CFA guidance with TCAs acting as ligand-inactivating barriers. Filled arrowheads denote colocalization, and open arrowheads show the lack thereof. Asterisks in (D1–D3)
mark blood vessels. Scale bars: A, 500m; A1, A2, B, D1, 12m; A2 inset, B1, D1 inset, 3m.
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by exposing cortical neurons to lactacystin (20 M) to inactivate
the catalytic site of the 20S proteasome (Omura et al., 1991).
Because UPS inhibition affects the turnover of many proteins
essential for neuronal survival or differentiation, we have estab-
lished in vitro conditions in which UPS inhibition does not com-
promise cell viability (Fig. 7E) but affects MGL turnover (Fig.
7A–C). We find that UPS inhibition disrupts MGL distribution
such thatMGL becomes indiscriminately present in the axon and
dendrites (Fig. 7B,C) and ventures into growth cones (Fig.
7C2,C3). Fluorescence intensity distribution analysis of MGL

axons revealed that UPS inhibition dissipates the spatial segrega-
tion of MGL (established) and actin (motile) axon segments
(Fig. 7D,E5). EctopicMGLaccumulation is observed in dendrites
during lactacystin-induced disruption of MGL turnover (Fig.
7C,F–H1).
If 2-AG hydrolysis by MGL impedes axonal growth, then dis-
rupting the subcellular distribution of MGL will shorten axon
length. Although an impaired UPS can increase the bioavailabil-
ity of many proteins pivotal for axonal growth and thus disturb
combinatorial signaling in growth cones, we argued that our
model allows testing the premise that a molecular link between
MGL stabilization in axons and discordant neurite outgrowth
can exist. We find that UPS inhibition reduces the length of the
lead neurite (Fig. 7E1) and prunes both axon collateral complex-
ity (Fig. 7B,C,E2) and dendritogenesis (Fig. 7H) of cortical neu-
rons. These findings suggest that MGL turnover is differentially
regulated in the motile and consolidated axon segments and can
affect axonal elongation.
Synaptogenesis disrupts the axonal MGL microgradient
Although MGL primarily avoids the motile neurite segment, it
accumulates in presynapses of cultured neurons (Fig. 8) as well as
many presynaptic terminals of the adult cerebral cortex (Dinh et
al., 2002; Gulyas et al., 2004; Kano et al., 2009). This presents the
possibility that MGL redistribution in the growth cone is physi-
ologically relevant to decrease the velocity of 2-AG-induced mo-
tility when a growth cone approaches its postsynaptic target.
Therefore, we have determined whether subcellular MGL distri-
bution changes during synaptogenesis. We find that MGL accu-
mulates in growth cones that appose a postsynaptic neuron in
vitro (Fig. 8A–B3) (supplemental Fig. 6A,D–D2, available at
www.jneurosci.org as supplemental material). In contrast,
growth cones of axon collaterals who have not selected a target
remain MGL (Fig. 8A) (supplemental Fig. 6A–C2). These data
suggest that the axonal polarity of MGL dissipates and MGL can
limit 2-AG signaling as a growth cone engages in its postsynaptic
target selection (Fig. 8C,C1).
MGL inhibition induces axonal growth
Although evidence is accumulating that CB1Rs affect (in isolation
or synergistically with other receptors) axonal growth and steer-
ing decisions, evidence on the molecular identity of the eCB re-
quired for axonal growth is still lacking.Our findings could imply
that 2-AGmay function as an axonal elongation signal.We tested
this possibility by inhibiting the enzymatic activity of MGL with
JZL184 (100 nM), a selective MGL inhibitor (Long et al., 2009).
Exposure to JZL184 (16 h) invariably triggers neurite outgrowth
in both cells that emit a stunted quiescent axon shortly after
plating (Fig. 9A–B2) and neurons with an established primary
neurite in vitro (Fig. 9C–C2). We have confirmed these data by
applying URB 602 (5 M), an alternative MGL inhibitor (King et
al., 2007), whose application also increases axonal growth (data
not shown). Notably, MGL inhibition regulates neither the
length of the actindistal neurite segment (Fig. 9B2,C2) nor com-
partmentalized MGL distribution (data not shown) in axons,
thus suggesting thatMGL inactivation does not directly influence
MGL degradation.
Overall, our data suggest that MGL exerts dual functions dur-
ing axonal growth: MGL may form an intracellular barrier keep-
ing lipophilic 2-AG from diffusing retrogradely from the growth
cone in the axonal plasma membrane to prematurely engage
CB1Rs and induce ectopic growth responses (Fig. 8C,C1). In ad-
dition, the exclusion of MGL from the motile neurite tip could
allow for cell-autonomous or target-derived 2-AG to selectively
impact the growth cone and trigger axonal elongation in a coor-
dinated manner.
2-AG is one of the many potential targets of MGL in vivo
(Nomura et al., 2010). It is therefore possible that MGL hydro-
lyzes a ligand distinct from 2-AG to regulate axonal elongation.
To exclude this possibility, we treated neurons with JZL184 in
combination with O-3841 or THL, DAGL inhibitors. We show
that coincident blockade of MGL and DAGL activities by JZL184
and either O-3841 [104.2 6.7 m (JZL184, n 39) vs 80.4
4.9m (JZL184O-3841, n 40); p 0.005] (Fig. 9D–D2,F1) or
Figure 5. DAGL andMGL expression in CB1R
/ telencephalon.A, CB1Rs decorate corticofugal axons coursing in the cortical IZ and descending in fascicles through striatal patches.A1, Axonal
CB1R immunoreactivity is entirely absent inCB1R
/mice.B,B1, DAGLexpression is essentially unchanged inCB1R
/brains inboth the cerebral cortex and thehippocampal fimbria (B, arrow).
At cellular resolution, DAGL localizes to radial glia fibers and enlarged axon clusters in the IZ of CB1R
/mice (B1, arrows). C, C1, Similarly, CB1R deletion does not affect MGL expression in (C1)
and targeting to (C1, arrows) axons in the cerebral cortex. Open rectangles identify the location of insets in A–C1. Scale bars, 50m.
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THL[104.26.7m(JZL184,n39)vs64.54.3m(JZL184
THL, n  32); p  0.001] abolishes the JZL184-induced growth
response. We verified that the effect of 2-AG is mediated by
CB1Rs by showing that O-2050, a neutral CB1R antagonist, sig-
nificantly attenuates JZL184-induced neurite extension [104.2
6.7 m (JZL184, n  39) vs 84.3  6.6 m (JZL184  O-2050,
n 35); p 0.036] (Fig. 9D1 vs D3,F1). Neuronal morphology
was not compromised by any of the drugs used, as reflected by
an unchanged number of processes (Fig. 9F2).
Endocannabinoids have been shown to induce repulsive
growth cone turning by activatingRhoAGTPases (Berghuis et al.,
2007). A repulsive response of motile growth cones will invari-
ably couple to axonal elongation because directional growth is
required to avoid the chemorepulsive cue. This phenomenon can
also exist when ligands are indiscriminately present in culture
media, as in our model, with the outcome being structural rear-
rangements within the growth cone and chaotic axonal elonga-
tion. Therefore, determining the growth cone size will reveal
whether surplus 2-AG impacts growth cone morphology in neu-
rons deficient in MGL activity. Growth cones of cortical pyrami-
dal cells retained chaotic filopodial complexity in vitro (Fig. 9E1)
and in vivo (Fig. 3C). JZL184 induced a growth cone phenotype
reminiscent of immature motile neurite tips [surface size, 8.57
1.16 m2 (JZL184, n  24) vs 15.78  1.55 m2 (control, n 
33); p 0.001] (Fig. 9G) possessing a lead filopodium (Fig. 9E2).
O-3841 [surface size, 15.92  2.00 m2 (n  25); p  0.003 vs
Figure 6. Differential subcellular targeting of DAGL andMGL during axon development. A, A1, In primary cortical cultures, DAGL andMGL are cotargeted to growing axons and often coexist in stable
varicosities (B, arrowheads). During axon fasciculation (C) and postsynaptic targeting (D), DAGL (Bisogno et al., 2003) but not MGL (arrowheads) is eliminated from axons and presynapses. D1, VAMP2
(synaptobrevin2)wasusedtovisualizepresynapticspecializations.E,MGLisselectivelytraffickedintothequiescentprematureaxon(a)andaccumulates in itsproximalsegmentassoonasneuronalpolarization
commences. In neurites with looped growth cones (E1), fluorescence signal separation reveals mutually exclusive distribution of actin and MGL in motile axons (a; open rectangle) or dendrites (d). E2, MGL
microgradients are invariably present in coexisting neurites with bundled (gc1), spread (gc2), or looped (gc3) growth cones. E3,E3, The presence of MGL in established axon segments and presynapse-like
varicosities (arrows) is maintained in elaborate axonal meshworks in vitro. F, F1, Subcellular MGL and DAGL targeting is strikingly different, with MGL being primarily excluded from the motile neurite tip
(arrow).Arrowheads indicate thetransitionpointbetweenMGLandMGLdomains.G,MGL immunofluorescence intensitymeasured in individualbundled/spread(left)or looped(right)growthcones(gcs)
and adjoining distal axon segments. Individual fluorescence intensity plots are in gray, and average values are in blue/red. Scale bars:A–C1,D1, F–G1, 10m; E, 3m.
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JZL184] (Fig. 9E3,G) but not THL ( p  0.738 vs JZL184) (Fig.
9G) significantly reduced JZL184-induced growth cone remod-
eling. Similarly, CB1Rblockade byO-2050markedly impeded the
JZL184-induced reduction of growth cone size [surface size,
12.36  1.81 m2 (n  26); p  0.085 vs JZL184] (Fig. 9G). In
summary, our data reconcile that 2-AG can act as both a direc-
tional cue (Berghuis et al., 2007) and an elongation factor while
sculpting axonal complexity.
Discussion
MGL in the developing nervous system
The prevailing view that eCBs, particularly 2-AG, exert many
functions in the developing nervous system is underscored by a
rapidly expanding cohort of experimental studies demonstrating
eCB-dependent neural progenitor self-renewal and neurogenic
commitment (Aguado et al., 2005, 2006; Goncalves et al., 2008),
long-range as well as local neuronal migration (Berghuis et al.,
2005; Morozov et al., 2009) and synaptogenesis (Berghuis et al.,
2007). eCB signaling is likely to coexist and cooperate with sig-
naling cascades indispensable for neuronal identification, includ-
ing neurotrophins (Maison et al., 2009) and chemokines (Zorina
et al., 2010). Compelling evidence indicates that both DAGL-
dependent 2-AG synthesis and CB1R-dependent signal transduc-
tion are under cell-state-specific regulatory control of BDNF
(Maison et al., 2009) and FGF receptor signaling cascades (Williams
et al., 2003). It is not surprising therefore that eCBactions underpin-
Figure 7. Proteasomal degradation excludes MGL from the motile neurite segment. A, Lactacystin increases MGL levels in primary cortical neurons. -III-Tubulin (Tuj1) was used as loading control.
LactacystinstabilizesMGLintheleadneuriteandeliminatesitsmicrogradient(C,C1)otherwiseseenincontrolcells(B,B1;seealsoE5).LactacystindisruptsaxonalMGLtargetingwithstabilizedMGLaccumulating
in both axonal (arrows) and dendritic (arrowheads) growth cones. B2–C3, MGL distribution in motile axon segments at high resolution. D, Fluorescence intensity plots reveal that proteasome inhibition
significantly increasesaxonalMGLcontent. Individualandaverage fluorescence intensityplotsaredepicted ingrayandblue/redcolors, respectively.E, Lactacystin (24h)doesnotcompromiseneuronalviability.
However, lactacystindecreasedthe rateofaxonalelongation(E1), inhibitsaxonalbranching(E2), and increases thenumberofMGL
axoncollaterals (E3)without shorteningorcollapsingthemotileneurite tip
(E4). Lactacystin also suppresseddendritogenesis (F–H) and stabilizedMGLventures intoproximal dendrites (G–G2, arrowheads,H1). **p0.01 (Student’s t test);n15–20 cells per group. Scale bars:B1,
C1, 20m;B3, C3, F2,G2, 10m.
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ning neuronal diversification and axonal growth are precisely timed
and spatially coordinated in the developing brain (Bisogno et al.,
2003). The precision of 2-AG signaling in a neurodevelopmen-
tal context is emphasized by the translocation of DAGLs from
axonal tracts once synaptogenesis concludes (Bisogno et al.,
2003) to dendritic spines apposing mature presynapses to main-
tain retrograde signaling (Katona et al., 2006; Yoshida et al.,
2006). 2-AG degradation by MGL, and probably also by ABHD6
and ABHD12 lipases (Blankman et al., 2007; Hashimotodani et
al., 2007; Straiker et al., 2009), is critical tomaintain the temporal
dynamics of retrograde synaptic communication and the sensi-
tivity of presynaptic CB1Rs to activity-dependent transient peaks
of extracellular 2-AG concentrations. It is therefore physiologi-
cally necessary to place MGL into the presynapse (Gulyas et al.,
2004) in which it can rapidly terminate 2-AG signaling
(Hashimotodani et al., 2007).
Dynamic subcellular recruitment of
both metabolic and receptor components
of 2-AG signaling networks in the devel-
oping nervous system is achieved through
cell-autonomous programming of both
the expression and subcellular sorting of
DAGLs, MGL, and CB1Rs. We find that
MGL is coincidently expressed with
CB1Rs and DAGLs by E12 in mouse, thus
providing critical hydrolytic activity to
terminate undesired 2-AG actions when
the telencephalic SVZ progenitor pool be-
gins to expand. The differential recruit-
ment of MGL to distinct subcellular
domains of neurons, particularly the con-
solidated axon shaft, provides an appeal-
ing candidate for the cell-autonomous
regulation of 2-AG-dependent positional
activation of CB1Rs. In fact, neurons can
spatially confine their 2-AG-inactivating
enzymatic capacity intracellularly such
that CB1Rs are kept inactive while under-
going vesicular transport along the axon
even in the presence of membrane-
diffusible 2-AG. Because agonist activa-
tion of CB1Rs can result in surplus neurite
branching in vitro (Mulder et al., 2008),
the molecular arrangements we uncov-
ered suggest that MGL activity in the
immotile axon shaft is required and suf-
ficient to prevent discordant signaling
events that could manifest in ectopic
branching and axon guidance errors.
Transient removal of MGL from ax-
onal tracts during the perinatal period
(E18.5 to P2) may have intriguing physi-
ological implications. The arrest of MGL
in neuronal perikarya and dendrites coin-
cideswith a previously reported, yet unex-
plained, peak (up to 
9 ng/g tissue) in
perinatal tissue 2-AG levels (Berrendero
et al., 1999). Our analysis significantly ex-
tends these observations by showing that
2-AG levels are increased as a result of a
transient lack of 2-AG hydrolysis capacity
in the neonatal hippocampus (up to
45
ng/g tissue) with minor changes in other
brain regions. We suggest that the neonatal 2-AG peak in the
hippocampus can provide a mechanism to mute synaptic infor-
mation processing, thus preventing memory formation during
delivery.
An 
1000-fold excess of tissue 2-AG concentrations over
those of AEA exists in the fetal brain (Berrendero et al., 1999).
This observation together with our detailed understanding of the
metabolic network controlling 2-AG bioavailability (Bisogno et
al., 2003; Nomura et al., 2010) prompted the molecular dissec-
tion of neurodevelopmental 2-AG signaling. Nevertheless, in
vitro data (Aguado et al., 2005; Berghuis et al., 2005;Mulder et al.,
2008) convincingly demonstrate that AEA can also elicit phys-
iologically relevant CB1R-mediated responses in developing
neurons. AEA may also be involved in fine-tuning 2-AG bio-
availability (Maccarrone et al., 2008). Hence, we expect future
studies to unravel AEA-specific signaling events and add an ad-
Figure8. Synaptogenesis coincideswith subcellularMGL redistribution.A,A1, Postsynaptic target selection coincideswithMGL
redistribution along the axon and the growth cone (1; arrowheads). In the meantime, motile axon collaterals lack MGL (2 and 3;
openarrowheads). Open rectangle indicates theposition ofB1–B3, showingMGLbeingpresent in the central growth conedomain
but not filopodia (fil) as well as in a putative postsynaptic target (pst; arrowhead).Workingmodel of the developmental functions
of MGL (C) and its redistribution during synapse formation (C1). Scale bars: A, A1, 20m; B3, 2m.
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ditional level of signaling complexity when alternative eCBs are
present, with eCBs conferring specific modalities to neuronal
subclass diversification during nervous system induction.
Positional ligand inactivation confers spatial specificity in
2-AG signaling
Our quantitative morphometry demonstrates that MGL can co-
exist with both CB1Rs and DAGL to promote cell-autonomous
axonal growth of neocortical pyramidal cells. In contrast, CB1Rs
are absent from MGL TCAs. We attribute the scarce coexist-
ence of MGL/CB1R
 axonal profiles in thalamic territories to
CTAs invading particular nuclei. The remarkable neurochemical
dichotomy of CFAs and TCAs in the context of 2-AG signaling
led us to propose novel roles for 2-AG signaling during the
“handshake” of these axons. The handshake hypothesis implies
that axons from the thalamus and from early-born cortical pre-
plate cells meet and intermingle in the basal telencephalon, after
which thalamic axons use the scaffold of CFAs to enter the corti-
cal plate (Molna´r and Blakemore, 1995). Our findings provide an
additional facet of information to this hypothesis by identifying
MGL-mediated 2-AG inactivation in TCAs as a mechanism to
limit unwanted 2-AG spillover likely masking steep local ligand
microgradients, to refine the extracellular 2-AG microgradient
map, and to determine CB1R-dependent directional CFA growth
(Fig. 4E). The ability of 2-AG to act as an extracellular guidance
signal is suggested by impaired retrograde signaling inDAGL/
Figure9. MGL inhibition induces axonal growth.A,A1, JZL184 induces elongation of the primary neurite of cortical neurons (arrows) relative to controls. The initial point of axonalMGL gradients
decrementing toward theactingrowth cones is indicatedbyarrowheads.B–C2, JZL184-inducedaxonal elongation is unrelated to the timeofdrugexposure. Cortical neuronswere seeded for short
(B–B2) or prolonged (C–C2) periods and subsequently exposed to JZL184.MGL inhibition invariably evokes an axonal growth response (B1, C1). JZL184does not affect either the length of themotile
actin neurite tip (B2, C2). D–D3, DAGL inhibition by O-3841 as well as CB1R blockade by O-2050 abolishes JZL184-induced neurite outgrowth (F1) without affecting the number of neurites (F2).
E1–E4, Both O-3841 and O-2050 markedly alleviate JZL184-induced growth cone collapse (G). Note that THL and O-3841 exert differential effects on growth cone size. *p 0.05, **p 0.01
(Student’s t test); n 25–40 cells per group. Scale bars: A1, D2, D3, 20m; E1–E4, 3m.
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mice (Gao et al., 2010; Tanimura et al., 2010), demonstrating that
2-AG can be liberated from specific neuronal compartments to
engage presynaptic CB1Rs after commuting in the extracellular
matrix.
Reconciling eCB-induced chemorepulsion and axonal growth
Because CB1R activation powerfully induces cytoskeletal rear-
rangements (Ishii and Chun, 2002), focal 2-AG catabolism is
critical to isolate cellular microdomains in which 2-AG-induced
activation of CB1Rs will evoke a specific growth response. CB1R
activation in axonal growth cones of cortical neurons has been
shown previously to induce chemorepulsive steering decisions
when presenting an extracellular ligandmicrogradient (Berghuis
et al., 2007). Because both attractive and repulsive extracellular
guidance cues must elicit cytoskeletal remobilization of the distal
(motile) axon segment to facilitate axonal elongation (either to-
ward or away from the source of the guidance molecule), CB1R-
dependent repulsive growth cone turning ultimately relies on the
directional extension of themotile axon segment (Berghuis et al.,
2007), with RhoA GTPases triggering cytoskeletal remodeling in
the navigating growth cone.
Exposing neurons to homogenously distributed ligands, such
as the bath-applied enzyme inhibitors or CB1R agonists used
here, will evoke neurite outgrowth. However, bath application
will eliminate the ability of the chemotropic ligand to evoke di-
rectional growth responses. Instead, axonal trajectories will be
chaotic in the absence of discrete synthesis and release sites.
Therefore, the experimental paradigm we used will only allow us
to study whether 2-AG can promote axonal growth per se. Be-
cause MGL inhibition by JZL184 couples to an axonal growth
response, we conclude that 2-AG clearly possesses such a capacity
when engaging CB1Rs in growth cones. It is noteworthy that
JZL184-treated neurons exhibit axonal growth cone morpholo-
gies reminiscent of those seen after gradient CB1R activation
(Berghuis et al., 2007): a clear reduction in the number of filop-
odia as well as in the surface size of growth cones argues that
massive growth cone remodeling occurs when 2-AG levels be-
come elevated. Our finding that O-3841 but not THL reinstates
the size and filopodial complexity of axonal growth cones hints
that these antagonists may differentially affect DAGL or
DAGL and can have different efficacies to block 2-AG synthesis
or off-target effects [e.g., THL can inhibit ABHD12 (Hoover et
al., 2008)] in developing neurons.
Overall, our data strongly suggest that 2-AG signaling exerts
dual roles in developing neurons by impacting both growth cone
navigation and axonal elongation. In this regard, the refined pro-
teasomal regulation of MGL might not only contribute to the
maintenance of axonal 2-AGmicrogradients but can also rapidly
reconfigureMGLdistribution to occlude protrusive 2-AG signal-
ing. Such a mechanism can be particularly powerful to act as a
halting signal to prevent aberrant elongation of an axon beyond
its physiologically appropriate postsynaptic target. Notably,
MGL stabilization (“overexpression”) and inhibition inversely
modulate 2-AG availability, which translates into a differential
axon growth response regardless of the stage of axon develop-
ment. The magnitude of axonal growth we observed cannot be
augmented by prolonged MGL inhibition, suggesting CB1R de-
sensitization or accelerated receptor recycling and removal
(Hsieh et al., 1999) once 2-AG levels reach a critical supraphysi-
ological threshold.
MGL is generally viewed to degrade 2-AG in the brain.
However, Nomura et al. (2010) have reported recently that
MGL can degrade a broad variety of bioactive monoacylglyc-
erols. Therefore, we suggest that the developmentally defined
composition of the substrate pool of MGL will determine its
metabolic significance. Our experiments cumulatively suggest
that the primary target of MGL to modulate axonal growth
and guidance is an endogenous CB1R agonist synthesized by
DAGLs. Although we cannot entirely exclude the contribution
of alternative monoacylglycerols to developmental processes,
the above molecular characteristics together with an in vivo
inverse relationship between neonatal MGL expression and
tissue 2-AG concentrations suggest that 2-AG can be a physi-
ologically relevant candidate to mediate axonal growth re-
sponses. Assuming that subcellular accumulation of DAGLs
andMGL directly reflect their increased focal enzymatic activ-
ity, we conclude that the developmental role of MGL is to
sculpt the spatial dynamics of 2-AG-rich hotspots, allow-
ing 2-AG to function as a local protrusive signal facilitating
neurite elongation. Thus, the spatiotemporal control of 2-AG
metabolism is a key determinant of eCB signaling during
establishment of the wiring diagram in cortical neuronal
networks, and modifications to the subcellular control of
eCB actions may be intrinsic to the pathogenesis of congenital
disorders associated with aberrant telencephalic axon patterning.
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